Percheron Therapeutics (AU:PER) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Percheron Therapeutics’ director Charmaine Gittleson has increased her indirect stake in the company by purchasing an additional 1,666,666 fully paid ordinary shares, bringing her total to 2,399,999 shares. This move signals potential confidence in the company’s future prospects, likely interesting investors and market watchers.
For further insights into AU:PER stock, check out TipRanks’ Stock Analysis page.